FDA.reportPublic FDA data

lidocaine hydrochloride 0.025 MG/MG Topical Gel

RxCUI
1009433
RxNorm name
lidocaine hydrochloride 0.025 MG/MG Topical Gel
Display name
Lidocaine (Topical)
Full name
lidocaine hydrochloride 0.025 MG/MG Topical Gel
Term type
SCD
Status
Active
Strength
2.5%
Dose form
Gel
Route
Topical
Updated
2026-06-13 07:07:16

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102010
Active start
102010
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
lidocaine hydrochloride0.025 MG / 1 MGlidocainelidocaine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Gel346286

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
lidocaine6387

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRlidocaine hydrochloride 0.025 MG/MG Topical GelNAMES
RxNorm Namelidocaine hydrochloride 0.025 MG/MG Topical GelNAMES
RxNorm Synonymlidocaine hydrochloride 2.5 % Topical GelNAMES
TTYSCDATTRIBUTES
SPL_SET_ID4640395f-a76c-d022-e063-6294a90adde6CODES
SPL_SET_ID46640e6f-916a-0b17-e054-00144ff8d46cCODES
SPL_SET_ID4a4e2759-49ef-20db-e054-00144ff8d46cCODES
SPL_SET_IDab25c47d-bbe6-4e2b-9e39-dd9f4da3ee8cCODES
RxCUI1009433CODES
MMSL_CODECD5843CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
44224-1220-144224-1220After Burn 2.5% Lidocaine HClTender Corporation d/b/a Adventure Ready BrandsM017
55621-010-0155621-010Assured LIDOCAINE HYDROCHLORIDEZhejiang Jingwei Pharmaceutical Co., Ltd.M017

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01744224-1220After Burn 2.5% Lidocaine HClOTC MONOGRAPH DRUGTender Corporation d/b/a Adventure Ready Brands

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
44224122000rxnav_ndcsyes
44224122001rxnav_ndcsyes
44224512000rxnav_ndcsyes
44224512001rxnav_ndcsyes
55621001001rxnav_ndcsyes
44224000601rxnav_historical
44224512002rxnav_historical
51284054042rxnav_historical_indirect
59898020510rxnav_historical
59898020511rxnav_historical
59898020512rxnav_historical
59898020513rxnav_historical
69571000101rxnav_historical
69571000102rxnav_historical
69571000201rxnav_historical
69571000202rxnav_historical
90107512000rxnav_historical
90107512001rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ab25c47d-bbe6-4e2b-9e39-dd9f4da3ee8clidocaine hydrochloride 0.025 MG/MG Topical GelSCD4Drug Facts20231025
ab25c47d-bbe6-4e2b-9e39-dd9f4da3ee8clidocaine HCl 2.5 % Topical GelPSN4Drug Facts20231025
ab25c47d-bbe6-4e2b-9e39-dd9f4da3ee8clidocaine hydrochloride 2.5 % Topical GelSY4Drug Facts20231025
46640e6f-916a-0b17-e054-00144ff8d46clidocaine HCl 2.5 % Topical GelPSN3CVS All Purpose First Aid Kit20170221
46640e6f-916a-0b17-e054-00144ff8d46clidocaine hydrochloride 0.025 MG/MG Topical GelSCD3CVS All Purpose First Aid Kit20170221
46640e6f-916a-0b17-e054-00144ff8d46clidocaine hydrochloride 2.5 % Topical GelSY3CVS All Purpose First Aid Kit20170221
0c504ba8-8a40-43dd-8c68-62ed106b32a2lidocaine hydrochloride 0.025 MG/MG Topical GelSCD2Water-Jel Unburn20171201
0c504ba8-8a40-43dd-8c68-62ed106b32a2lidocaine hydrochloride 2.5 % Topical GelSY2Water-Jel Unburn20171201
0c504ba8-8a40-43dd-8c68-62ed106b32a2lidocaine HCl 2.5 % Topical GelPSN2Water-Jel Unburn20171201
0558cdc9-8523-4dd5-baa5-9a8b0af46f8clidocaine hydrochloride 0.025 MG/MG Topical GelSCD2BurnX™ PAIN RELIEVING BURN GEL20171024
0558cdc9-8523-4dd5-baa5-9a8b0af46f8clidocaine HCl 2.5 % Topical GelPSN2BurnX™ PAIN RELIEVING BURN GEL20171024
0558cdc9-8523-4dd5-baa5-9a8b0af46f8clidocaine hydrochloride 2.5 % Topical GelSY2BurnX™ PAIN RELIEVING BURN GEL20171024
4640395f-a76c-d022-e063-6294a90adde6lidocaine hydrochloride 2.5 % Topical GelSY1After Burn20251218
4640395f-a76c-d022-e063-6294a90adde6lidocaine HCl 2.5 % Topical GelPSN1After Burn20251218
4640395f-a76c-d022-e063-6294a90adde6lidocaine hydrochloride 0.025 MG/MG Topical GelSCD1After Burn20251218
4a4e2759-49ef-20db-e054-00144ff8d46clidocaine HCl 2.5 % Topical GelPSN1Easy Care Comprehensive First Aid Kit20170309
4a4e2759-49ef-20db-e054-00144ff8d46clidocaine hydrochloride 0.025 MG/MG Topical GelSCD1Easy Care Comprehensive First Aid Kit20170309
4a4e2759-49ef-20db-e054-00144ff8d46clidocaine hydrochloride 2.5 % Topical GelSY1Easy Care Comprehensive First Aid Kit20170309

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
4640395f-a76c-d022-e063-6294a90adde6After BurnTender Corporation d/b/a Adventure Ready Brands20251218
ab25c47d-bbe6-4e2b-9e39-dd9f4da3ee8cDrug FactsZhejiang Jingwei Pharmaceutical Co., Ltd.20231025
4a4e2759-49ef-20db-e054-00144ff8d46cEasy Care Comprehensive First Aid KitTender Corporation20170309
46640e6f-916a-0b17-e054-00144ff8d46cCVS All Purpose First Aid KitCVS | Tender Corporation20170221

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN01BBAmidesATC1-4lidocaine
ATCS02DAAnalgesics and anestheticsATC1-4lidocaine
ATCD04ABAnesthetics for topical useATC1-4lidocaine
ATCR02ADAnesthetics, localATC1-4lidocaine
ATCC01BBAntiarrhythmics, class IbATC1-4lidocaine
ATCS01HALocal anestheticsATC1-4lidocaine
ATCC05ADLocal anestheticsATC1-4lidocaine
FDASPLN0000175682Amide Local AnestheticEPChas_epclidocaine
FDASPLN0000175426AntiarrhythmicEPChas_epclidocaine
FDASPLN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine hydrochloride
MEDRTD008012LidocaineCHEMhas_ingredientlidocaine
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine hydrochloride
MEDRTD000219Adams-Stokes SyndromeDISEASEci_withlidocaine
MEDRTD002056BurnsDISEASEmay_treatlidocaine hydrochloride
MEDRTD002056BurnsDISEASEmay_treatlidocaine
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine
MEDRTD064420Drug-Related Side Effects and Adverse ReactionsDISEASEmay_treatlidocaine hydrochloride
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine
MEDRTD004935Esophageal DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine hydrochloride
MEDRTD006967HypersensitivityDISEASEci_withlidocaine
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine hydrochloride
MEDRTD009059Mouth DiseasesDISEASEmay_treatlidocaine
MEDRTD009203Myocardial InfarctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine hydrochloride
MEDRTD010146PainDISEASEmay_preventlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine
MEDRTD010146PainDISEASEmay_treatlidocaine hydrochloride
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine
MEDRTD013614Tachycardia, ParoxysmalDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatlidocaine
MEDRTD018754Ventricular DysfunctionDISEASEmay_treatlidocaine hydrochloride
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine
MEDRTD014693Ventricular FibrillationDISEASEmay_treatlidocaine hydrochloride
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine
MEDRTD018879Ventricular Premature ComplexesDISEASEmay_treatlidocaine hydrochloride
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moalidocaine hydrochloride
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine
MEDRTN0000008330Cardiac Rhythm AlterationPEhas_pelidocaine hydrochloride
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008472Decreased Cardiac Muscle Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pelidocaine hydrochloride
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine
MEDRTN0000175976Local AnesthesiaPEhas_pelidocaine hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.025 MG/MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESMMSL_CODECD5843
CODESRxCUI1009433
CODESSPL_SET_ID4640395f-a76c-d022-e063-6294a90adde6
CODESSPL_SET_ID46640e6f-916a-0b17-e054-00144ff8d46c
CODESSPL_SET_ID4a4e2759-49ef-20db-e054-00144ff8d46c
CODESSPL_SET_IDab25c47d-bbe6-4e2b-9e39-dd9f4da3ee8c
NAMESPrescribable Synonymlidocaine HCl 2.5 % Topical Gel
NAMESRXNAV_STRlidocaine hydrochloride 0.025 MG/MG Topical Gel
NAMESRxNorm Namelidocaine hydrochloride 0.025 MG/MG Topical Gel
NAMESRxNorm Synonymlidocaine hydrochloride 2.5 % Topical Gel
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceNational Drug Data File Plus Source Vocabulary